Literature DB >> 6849769

Kinetics of oral trifluoperazine disposition in man.

K K Midha, E D Korchinski, R K Verbeeck, R M Roscoe, E M Hawes, J K Cooper, G McKay.   

Abstract

The disposition of trifluoperazine (TFP) was studied in five healthy volunteers following oral administration of a 5 mg tablet. Using a very sensitive GC-MS technique plasma TFP concentrations were measured up until 24 h following drug ingestion. Peak plasma concentrations varied widely (range 0.53-3.09 ng ml-1) and were reached 2.8 +/- 0.5 h following ingestion of the TFP tablet. The apparent terminal elimination half-life of TFP was 12.5 +/- 1.4 h. The area under the plasma concentration-time curve differed widely between subjects (range: 5.9-17.6 ng ml-1 h) suggesting large individual differences in the extent of presystemic TFP elimination.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849769      PMCID: PMC1427786          DOI: 10.1111/j.1365-2125.1983.tb01515.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Fluphenazine, trifluoperazine and perphenazine in Vacutainers.

Authors:  K K Midha; J K Cooper; Y D Lapierre; J W Hubbard
Journal:  Can Med Assoc J       Date:  1981-02-01       Impact factor: 8.262

Review 3.  Presystemic drug elimination.

Authors:  P A Routledge; D G Shand
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

4.  Formation of identical metabolites from piperazine- and dimethylamino-substituted phenothiazine drugs in man, rat and dog.

Authors:  U Breyer; H J Gaertner; A Prox
Journal:  Biochem Pharmacol       Date:  1974-01-15       Impact factor: 5.858

5.  Analysis of plasma trifluoperazine by gas chromatography and selected ion monitoring.

Authors:  R Whelpton; S H Curry; G M Watkins
Journal:  J Chromatogr       Date:  1982-03-12

6.  A gas chromatographic mass spectrometric assay for plasma trifluoperazine concentrations following single doses.

Authors:  K K Midha; R M Roscoe; K Hall; E M Hawes; J K Cooper; G McKay; H U Shetty
Journal:  Biomed Mass Spectrom       Date:  1982-05

7.  Metabolism and disposition of trifluoperazine in the rat. I. A thin-layer chromatographic method for the measurement of trifluoperazine and its metabolites in rat tissues.

Authors:  U Breyer; G Schmalzing
Journal:  Drug Metab Dispos       Date:  1977 Mar-Apr       Impact factor: 3.922

8.  Sensitive gas chromatographic determination of trifluoperazine in human plasma.

Authors:  T J Gillespie; I G Sipes
Journal:  J Chromatogr       Date:  1981-04-10

9.  A GLC-nitrogen phosphorous detector assay for trifluoperazine in plasma.

Authors:  R M Roscoe; J K Cooper; E M Hawes; K K Midha
Journal:  J Pharm Sci       Date:  1982-06       Impact factor: 3.534

10.  Radioimmunoassay for trifluoperazine in human plasma.

Authors:  K K Midha; J W Hubbard; J K Cooper; E M Hawes; S Fournier; P Yeung
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

View more
  7 in total

1.  Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.

Authors:  Emilie A G Molins; William J Jusko
Journal:  AAPS J       Date:  2018-06-27       Impact factor: 4.009

2.  Single-dose kinetics of the neuroleptic drug perazine in psychotic patients.

Authors:  U Breyer-Pfaff; K Nill; H W Schied; H J Gaertner; H Giedke
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Kinetics of oral fluphenazine disposition in humans by GC-MS.

Authors:  K K Midha; G McKay; R Edom; E D Korchinski; E M Hawes; K Hall
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Plasma concentrations of trifluoperazine following single low doses.

Authors:  K K Midha; E M Hawes; G McKay; J W Hubbard; E D Korchinski; D L Keegan
Journal:  Can Med Assoc J       Date:  1983-08-15       Impact factor: 8.262

5.  A pharmacokinetic study of trifluoperazine in two ethnic populations.

Authors:  K K Midha; E M Hawes; J W Hubbard; E D Korchinski; G McKay
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 6.  Emergency treatment of psychotic symptoms. Pharmacokinetic considerations for antipsychotic drugs.

Authors:  G V Milton; M W Jann
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

7.  New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection.

Authors:  Jourdan A Andersson; Alex G Peniche; Cristi L Galindo; Prapaporn Boonma; Jian Sha; Ruth Ann Luna; Tor C Savidge; Ashok K Chopra; Sara M Dann
Journal:  mBio       Date:  2020-03-10       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.